Login to Your Account

'Fours' company: Start-up Tetra thinks about new pathways in cognitio

By Randy Osborne
Staff Writer

Wednesday, April 9, 2014
"It's not the usual model," explained Mark Gurney, CEO of Tetra Discovery Partners LLC, which is collaborating with the Broad Institute's Stanley Center for Psychiatric Research on drugs that might help cognitive impairment in schizophrenia.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription